196 related articles for article (PubMed ID: 19937438)
1. Neurofibromatosis type 1 and high-grade tumors of the central nervous system.
Rosenfeld A; Listernick R; Charrow J; Goldman S
Childs Nerv Syst; 2010 May; 26(5):663-7. PubMed ID: 19937438
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 and sporadic optic gliomas.
Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
[TBL] [Abstract][Full Text] [Related]
4. An update on the central nervous system manifestations of neurofibromatosis type 1.
Nix JS; Blakeley J; Rodriguez FJ
Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1 and malignancy in childhood.
Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
[TBL] [Abstract][Full Text] [Related]
8. Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
Strowd RE; Rodriguez FJ; McLendon RE; Vredenburgh JJ; Chance AB; Jallo G; Olivi A; Ahn ES; Blakeley JO
Am J Med Genet A; 2016 Jun; 170(6):1455-61. PubMed ID: 26992069
[TBL] [Abstract][Full Text] [Related]
9. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
10. Nonoptic pathway tumors in children with neurofibromatosis type 1.
Mahdi J; Goyal MS; Griffith J; Morris SM; Gutmann DH
Neurology; 2020 Aug; 95(8):e1052-e1059. PubMed ID: 32300062
[TBL] [Abstract][Full Text] [Related]
11. Gliomas in patients with neurofibromatosis type 1.
Albers AC; Gutmann DH
Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
[TBL] [Abstract][Full Text] [Related]
12. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
13. Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.
Cecen E; Ince D; Uysal KM; Ozer E; Cetingoz R; Ozguven AA; Cakmakci H; Sarialioglu F; Olgun N
Childs Nerv Syst; 2011 Nov; 27(11):1885-93. PubMed ID: 21442270
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.
Huttner AJ; Kieran MW; Yao X; Cruz L; Ladner J; Quayle K; Goumnerova LC; Irons MB; Ullrich NJ
Pediatr Blood Cancer; 2010 Jul; 54(7):890-6. PubMed ID: 20310005
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.
Li J; Perry A; James CD; Gutmann DH
Neurology; 2001 Apr; 56(7):885-90. PubMed ID: 11294925
[TBL] [Abstract][Full Text] [Related]
16. Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?
Korones DN; Padowski J; Factor BA; Constine LS
Neuro Oncol; 2003 Apr; 5(2):116-20. PubMed ID: 12672283
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature.
Afşar CU; Kara IO; Kozat BK; Demiryürek H; Duman BB; Doran F
Crit Rev Oncol Hematol; 2013 May; 86(2):191-9. PubMed ID: 23218951
[TBL] [Abstract][Full Text] [Related]
18. [Brain stem tumors associated with neurofibromatosis type 1. Presentation of 20 infantile patients].
Pascual Castroviejo I; Pascual Pascual S; Velázquez Fragua R; Viaño J; Garcia Segura JM
Neurologia; 2007 Dec; 22(10):846-52. PubMed ID: 17671854
[TBL] [Abstract][Full Text] [Related]
19. The management of brainstem gliomas in patients with neurofibromatosis 1.
Pollack IF; Shultz B; Mulvihill JJ
Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565
[TBL] [Abstract][Full Text] [Related]
20. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
